Wells Fargo Downgrades Centessa Pharmaceuticals (CNTA) to Equal Weight

April 20, 2026 5:14 AM

Wells Fargo analyst Benjamin Burnett downgraded Centessa Pharmaceuticals (NASDAQ: CNTA) from ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found